Culver City, California
United States
8
2018-06-07
8
2020-09-08
These are the the leading inventors for applications assigned to NantBioScience, Inc.:
NantBioScience, Inc. based in Culver City, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pyrimidine derivatives as kinase inhibitors and their therapeutical applications
#2 | 2017-06-27 ✅ Patent 9,687,491 granted on 2017-06-27Compositions and methods of targeting mutant K-Ras
#3 | 2016-01-21 ✅ Patent 9,550,760 granted on 2017-01-24Substituted indol-5-ol derivatives and their therapeutic applications
#4 | 2015-10-22 ✅ Patent 9,499,539 granted on 2016-11-22Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
#5 | 2015-10-15 ✅ Patent 9,458,137 granted on 2016-10-04Substituted indol-5-ol derivatives and their therapeutical applications
#6 | 2013-07-11 ✅ Patent 8,946,169 granted on 2015-02-03SPARC and methods of use thereof
#7 | 2012-10-25 ✅ Patent 9,345,699 granted on 2016-05-24Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
#8 | 2012-08-02 ✅ Patent 9,078,902 granted on 2015-07-14Triazine derivatives and their therapeutical applications
Also check out NantBioScience, Inc.'s (Culver City, United States) applicant profile with 8 patent applications submitted.
100110 ⎘